Related Experiment Videos
[Multifocal osteomyelitis as the first manifestation of chronic granulomatous disease]
F Launay1, J-M Sobler, I Kone-Paut
1Service de Chirurgie Orthopédique, Hôpital Timone Enfants, 264, rue Saint-Pierre, 13385 Marseille Cedex 5.
Insights
Chronic granulomatous disease (CGD) can present with multifocal osteomyelitis in children. Early diagnosis via blood tests and prompt treatment are crucial for managing this rare immune disorder.
Area of Science:
- Immunology
- Pediatrics
- Genetics
Background:
- Chronic granulomatous disease (CGD) is a rare primary immunodeficiency.
- It stems from a defect in phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase.
- Recurrent, severe infections are the hallmark clinical presentation of CGD.
Observation:
- This report details a case of a 22-month-old child.
- The child presented with multifocal osteomyelitis as an unusual initial symptom of CGD.
- Septic CGD is an infrequent consideration in pediatric recurrent infections.
Findings:
- Diagnosis of CGD relies on specific laboratory tests.
- These include the reduction of tetrazolium nitroblue (NBT), chemoluminescence assays, and molecular genetic analysis.
- Multifocal osteomyelitis was identified as an inaugural manifestation.
Implications:
- Prompt diagnosis and intervention are vital for improving long-term outcomes in CGD.
- Currently, no curative treatment exists for CGD.
- Management involves aggressive treatment of infections with antibiotics, potential surgical debridement, and long-term antibiotic prophylaxis.
Abstract:
Chronic granulomatous disease is a rare immune disease related to an anomaly in phagocytes NADPH oxidase. The characteristic clinical feature is early recurrent and sometimes serious infection. We report the case of a 22-month-old child who developed multifocal osteomyelitis, an unusual inaugural manifestation of chronic granulomatous disease. Septic chronic granulomatous disease is an uncommon differential diagnosis in children who develop recurrent infections. Diagnosis is established with specific blood tests: reduction of tetrazolium nitroblue, chemoluminescence test, molecular analysis. Therapeutic management must be undertaken as early as possible in order to preserve the long-term prognosis. No curative treatment is currently available. Aggressive treatment of each infectious focus with an adapted antibiotic regimen and in certain cases surgical debridement is required in addition to long-term antibiotic prophylaxis.
Related Concept Videos
Cryptococcal Meningitis
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Chronic Inflammation: Introduction
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...